A reorganisation of NHS dementia care is needed to ensure UK patients can receive a groundbreaking drug that slows the progression of Alzheimer's disease, doctors say.Detailed results from a clinical trial of lecanemab have confirmed that the drug reduces cognitive decline in patients with early-stage Alzheimer's, in a hard-won breakthrough hailed as a historic moment for the field.
#people #back #years #infrastructure #million-people #introduction #health-officials #breakthrough #chief-medical-officer
[
add
]
[
|
|
...
]